RP-3467

RP-3467 · Repare Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RP-3467, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Trial of RP-3467 Alone and in Combination With Olaparib in Participants With Advanced Solid Tumors [Phase 1]

See pricing